News
The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide ...
GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for ...
A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...
Copycats and false advertisements are also to blame for the increased threats. Stemming from social media testimonials all ...
4h
HealthDay on MSNGLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia RiskGlucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related ...
17h
News-Medical.Net on MSNGLP-1 receptor agonists linked to lower dementia risk in type 2 diabetesGLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for ...
17h
News-Medical.Net on MSNCan one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonistsLandmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...
23h
Everyday Health on MSNCan GLP-1 Patches Really Help You Lose Weight?Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...
Significant’ weight returned weeks after stopping drug, say researchers who advise patients to adjust expectations.
Restaurants are creating Ozempic menus with smaller meals for people who are taking GLP-1 weight-loss drugs and have a ...
The comedy club owner has since dropped a whopping 4st and currently weighs 13st, however, she has been left in tears due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results